Krishna Institute of Medical Sciences Limited (KIMS) Stock Statistics & Valuation Metrics

Krishna Institute of Medical Sciences Limited has a market cap or net worth of ₹250.57B. The enterprise value is ₹281.79B.

Krishna Institute of Medical Sciences Limited has 400,138,950 shares outstanding. The number of shares has decreased by -2.65% in one year.

Krishna Institute of Medical Sciences Limited’s return on equity (ROE) is 0.18 and return on invested capital (ROIC) is 8.86%.

The current PE Ratio of Krishna Institute of Medical Sciences Limited is 114.0. Krishna Institute of Medical Sciences Limited’s PEG ratio is 2.68.

In the last 12 months, Krishna Institute of Medical Sciences Limited had revenue of 30.04B and earned 3.85B in profits. Earnings per share was 9.61.

In the last 12 months, operating cash flow was 2.85B and capital expenditures -7.53B, giving a free cash flow of -4.69B billion.

Krishna Institute of Medical Sciences Limited pays an annual dividend of ―, resulting in a dividend yield of ―

Krishna Institute of Medical Sciences Limited upcoming earnings date is May 14, 2026, Before Open (Confirmed).

Krishna Institute of Medical Sciences Limited as a current ratio of 0.83, with Debt / Equity ratio of 140.37%

In the past 12 months, Krishna Institute of Medical Sciences Limited has paid 1.43B in taxes.

Krishna Institute of Medical Sciences Limited EV to EBITDA ratio is 33.02, with an EV/FCF ratio of -63.71.

Krishna Institute of Medical Sciences Limited has ₹1.74B in cash and marketable securities with ₹31.87B in debt, giving a net cash position of -₹30.13B billion.

Gross margin is 61.24%, with operating margin of 20.52%, and net profit margin of 12.80%.

The average price target for Krishna Institute of Medical Sciences Limited is ₹792.50, which is 11.43% higher than the current price. The consensus rating is Strong Buy